Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril

G. Perani, C. Muggia, A. Martignoni, A. Bongarzoni, A. Radaelli, F. Testa, G. Finardi

Research output: Contribution to journalArticlepeer-review

Abstract

The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P

Original languageEnglish
Pages (from-to)635-639
Number of pages5
JournalClinical Therapeutics
Volume9
Issue number6
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril'. Together they form a unique fingerprint.

Cite this